KB425796-A, a novel antifungal antibiotic produced by Paenibacillus sp. 530603

J Antibiot (Tokyo). 2013 Aug;66(8):465-71. doi: 10.1038/ja.2013.63. Epub 2013 Jun 19.

Abstract

The novel antifungal macrocyclic lipopeptidolactone, KB425796-A (1), was isolated from the fermentation broth of bacterial strain 530603, which was identified as a new Paenibacillus species based on morphological and physiological characteristics, and 16S rRNA sequences. KB425796-A (1) was isolated as white powder by solvent extraction, HP-20 and ODS-B column chromatography, and lyophilization, and was determined to have the molecular formula C79H115N19O18. KB425796-A (1) showed antifungal activities against Aspergillus fumigatus and the micafungin-resistant infectious fungi Trichosporon asahii, Rhizopus oryzae, Pseudallescheria boydii and Cryptococcus neoformans.

MeSH terms

  • Antifungal Agents / chemistry
  • Antifungal Agents / isolation & purification
  • Antifungal Agents / pharmacology*
  • Aspergillus fumigatus / drug effects
  • Chromatography, High Pressure Liquid / methods
  • Cryptococcus neoformans / drug effects
  • Depsipeptides / chemistry
  • Depsipeptides / isolation & purification
  • Depsipeptides / pharmacology*
  • Drug Resistance, Fungal
  • Fermentation
  • Freeze Drying
  • Microbial Sensitivity Tests
  • Paenibacillus / metabolism*
  • Pseudallescheria / drug effects
  • RNA, Bacterial / genetics
  • RNA, Ribosomal, 16S / genetics
  • Rhizopus / drug effects
  • Sequence Analysis, RNA
  • Solvents / chemistry
  • Trichosporon / drug effects

Substances

  • Antifungal Agents
  • Depsipeptides
  • KB425796-A
  • RNA, Bacterial
  • RNA, Ribosomal, 16S
  • Solvents